MedTrace Logo

Intensive Statin Treatment for STEMI Patients Undergoing Primary PCI

NCT01033058 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 500

Last updated 2009-12-24

No results posted yet for this study

Summary

This is a retrospective, randomized, parallel, open-labeled, controlled study to find out whether STEMI patients undergoing emergency PCI can benefit from intensive atorvastatin treatment compared with routine treatment.

Conditions

  • STEMI

Interventions

DRUG

atorvastatin

80mg atorvastatin immediately after enrollment, emergency PCI,atorvastatin 40mg/d and other usual medication after PCI

DRUG

atorvastatin

No loading dose of statin after enrollment, emergency PCI, atorvastatin 20mg/d and other usual medication after PCI

Sponsors & Collaborators

  • Pfizer

    collaborator INDUSTRY

  • Beijing Chao Yang Hospital

    lead OTHER

Principal Investigators

  • Xinchun Yang, Prof. · Beijing Chaoyang Hospital, China

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-12-31
Primary Completion
2011-03-31
Completion
2011-06-30

Countries

  • China

Study Locations

More Related Trials

Entities

Drugs
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01033058 on ClinicalTrials.gov